Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a Head-Zap gadget tame Alzheimer's agitation?

NCT ID NCT05478681

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 36 times

Summary

This small study tested whether a home-use brain stimulation device (tDCS) is safe and acceptable for people with Alzheimer's who have behavioral symptoms like agitation or apathy. Only 3 participants completed the trial, with caregivers helping to set up the device. The main goals were to see if people would use it and if side effects were manageable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030, United States

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas, 78229, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transcranial direct current stimulation (tDCS) device

What this could lead to

If it works, this could point toward a safe, at-home way to reduce troubling behavioral symptoms in Alzheimer's patients.

What could go wrong

This was a tiny pilot study with only 3 participants, so results may not apply to others. tDCS can cause side effects like itching, headache, or dizziness.

Conditions

The condition(s) this trial relates to.

Alzheimer disease anxiety disorder Depression Lethargy Psychotic Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.